NewAmsterdam Pharma Company NV’s recent filing unveils that its Chief Operating Officer Kling Douglas F unloaded Company’s shares for reported $1.08 million on Jul 16 ’25. In the deal valued at $21.10 per share,51,043 shares were sold. As a result of this transaction, Kling Douglas F now holds 44,000 shares worth roughly $1.1 million.
Then, Kling Douglas F sold 47,569 shares, generating $1,019,648 in total proceeds. Upon selling the shares at $21.44, the Chief Operating Officer now owns 44,000 shares.
Before that, NAP PoolCo B.V. bought 1,433,193 shares. NewAmsterdam Pharma Company NV shares valued at $30,899,641 were divested by the Affiliate at a price of $21.56 per share.
Goldman initiated its NewAmsterdam Pharma Company NV [NAMS] rating to a Neutral in a research note published on July 17, 2025; the price target was $27. A number of analysts have revised their coverage, including Citigroup’s analysts, who began to cover the stock in mid June with a ‘”a Buy”‘ rating. Stifel began covering NAMS with “Buy” recommendation on June 10, 2025. Cantor Fitzgerald started covering the stock on June 04, 2025. It rated NAMS as “an Overweight”.
Price Performance Review of NAMS
On Tuesday, NewAmsterdam Pharma Company NV [NASDAQ:NAMS] saw its stock jump 2.59% to $25.0. Over the last five days, the stock has gained 15.05%. NewAmsterdam Pharma Company NV shares have risen nearly 47.84% since the year began. Nevertheless, the stocks have fallen -2.72% over the past one year. While a 52-week high of $27.29 was reached on 01/02/25, a 52-week low of $14.06 was recorded on 04/07/25.
Levels Of Support And Resistance For NAMS Stock
The 24-hour chart illustrates a support level at 24.33, which if violated will result in even more drops to 23.67. On the upside, there is a resistance level at 25.42. A further resistance level may holdings at 25.85.
How much short interest is there in NewAmsterdam Pharma Company NV?
A steep rise in short interest was recorded in NewAmsterdam Pharma Company NV stocks on 2025-07-31, growing by 0.3 million shares to a total of 7.18 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 6.88 million shares. There was a rise of 4.23%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on December 30, 2024 when H.C. Wainwright began covering the stock and recommended ‘”a Buy”‘ rating along with a $48 price target.
